Skip to main content
. 2019 Jun 24;11(1):1608141. doi: 10.1080/20002297.2019.1608141

Figure 7.

Figure 7.

Differentially abundant species between baseline (Day 0) and endpoint (Day 21) in the prevention sub-study. (a) Placebo group, (b) NAC group, and (c) CHX group. Differences were identified by linear discriminant analysis (LDA) effect size analysis (LEfSe); LDA score ≥3. NAC: N-acetyl cysteine; CHX: chlorhexidine.